The present authors performed an open-label pilot research that administered psilocybin to 15 treatment method-resistant tobacco/nicotine-dependent smokers, while in the context of cognitive behavioral therapy for using tobacco cessation [fifty eight]. Individuals ended up administered ~0.29 mg/kg oral psilocybin to the participant’s goal date to… Read More